Overview

Effect of Sirolimus on Molecular Alterations in Cerebral Aneurysms

Status:
Recruiting
Trial end date:
2026-11-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to explore the effects of Sirolimus on the underlying molecular alterations of cerebral aneurysms.
Phase:
Phase 2
Details
Lead Sponsor:
University of Miami
Collaborator:
National Institute of Neurological Disorders and Stroke (NINDS)
Treatments:
Everolimus
Sirolimus